Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 1636 AL 1650

Case Study 3: A 58-Year-Old Woman Referred for Evaluation of Suspected Alzheimer Dementia

Maneval J, Woods JK, Feany MB, Miller MB, Silbersweig DA, Gale SA, Daffner KR, McGinnis SM.

J Neuropsychiatry Clin Neurosci. 2022 Fall;34(4):307-315. doi: 10.1176/appi.neuropsych.20220113.

Hidden networks of aberrant protein transnitrosylation contribute to synapse loss in Alzheimer's disease

Lipton SA.

Free Radic Biol Med. 2022 Nov 20;193(Pt 1):171-176. doi: 10.1016/j.freeradbiomed.2022.10.272. Epub 2022 Oct 13.

Temporal Variation in Disease Onset and Clinical Features of Lewy Body Disease in China

Gan J, Chen Z, Shi Z, Li X, Liu S, Liu Y, Zhu H, Shen L, Zhang G, You Y, Guo Q, Zhang N, Lv Y, Gang B, Yuan J, Ji Y.

J Alzheimers Dis. 2022;90(3):1263-1275. doi: 10.3233/JAD-220657.

Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia

Li M, Fan Y, Li Q, Wang X, Zhao L, Zhu M.

Oxid Med Cell Longev. 2022 Oct 6;2022:7165387. doi: 10.1155/2022/7165387. eCollection 2022.

Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigation

Levendowski DJ, Walsh CM, Boeve BF, Tsuang D, Hamilton JM, Salat D, Berka C, Lee-Iannotti JK, Shprecher D, Westbrook PR, Mazeika G, Yack L, Payne S, Timm PC, Neylan TC, St Louis EK.

Sleep Med. 2022 Dec;100:501-510. doi: 10.1016/j.sleep.2022.09.025. Epub 2022 Oct 4.

[A role of human microbiota in the development of neurodegenerative diseases]

Epishina IV, Budanova EV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(10):57-65. doi: 10.17116/jnevro202212210157.

Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder

Nakhal MM, Aburuz S, Sadek B, Akour A.

Molecules. 2022 Oct 23;27(21):7174. doi: 10.3390/molecules27217174.

Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment

Kopp KO, Glotfelty EJ, Li Y, Greig NH.

Pharmacol Res. 2022 Dec;186:106550. doi: 10.1016/j.phrs.2022.106550. Epub 2022 Nov 11.

Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease

Anand S, Azam Ansari M, Kumaraswamy Sukrutha S, Alomary MN, Anwar Khan A, Elderdery AY.

Neuroscience. 2022 Dec 15;507:139-148. doi: 10.1016/j.neuroscience.2022.11.001. Epub 2022 Nov 11.

[Role of β2-Adrenergic Receptor Agonist in the Cognitive Impairment Associated with Neurodegenerative Diseases]

Wang ZJ, Guo WN, Guo QZ, Wang S, Wang TJ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Dec;44(6):1112-1116. doi: 10.3881/j.issn.1000-503X.14469.

Applications of nanobodies in brain diseases

Zheng F, Pang Y, Li L, Pang Y, Zhang J, Wang X, Raes G.

Front Immunol. 2022 Nov 8;13:978513. doi: 10.3389/fimmu.2022.978513. eCollection 2022.

Introduction: Unraveling the complex contributions of indigenous microbes to neurological health and disease

Sampson TR.

Int Rev Neurobiol. 2022;167:xi-xvi. doi: 10.1016/S0074-7742(22)00138-6.

Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction?

Guidetti M, Bertini A, Pirone F, Sala G, Signorelli P, Ferrarese C, Priori A, Bocci T.

Int J Mol Sci. 2022 Nov 9;23(22):13775. doi: 10.3390/ijms232213775.

Emerging Roles for the RNA-Binding Protein HuD (ELAVL4) in Nervous System Diseases

Silvestri B, Mochi M, Garone MG, Rosa A.

Int J Mol Sci. 2022 Nov 23;23(23):14606. doi: 10.3390/ijms232314606.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias